Refine by
Applications
- RNA Technology for Research Fellowship
- RNA Technology for Medical Areas of Focus Research
- RNA Technology for Product Pipeline Research
- RNA Technology for Clinical trials
- Solution for Clinical Trials
- Solution for Access to Investigational Medicines
- Isotopes for Medical
- Clean air solutions for allergens area
- Clean air solutions for pollution area
- Clean air solutions for bad odor area
- Clean air solutions for bacteria area
- Clean air solutions for virus area
- Medical diagnostics solutions for inflammatory bowel disease sector
- Medical diagnostics solutions for colorectal cancer sector
Cancer Disease Equipment & Supplies
163 equipment items found
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Carubicin hydrochloride also induces apoptosis by a mechanism independent of p53 or hypoxia-inducible factor HIF2. Carubicin hydrochloride has the potential for the research of cancer ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Firmonertinib inhibits EGFR active mutations as well as the T790M acquired resistant mutation. Firmonertinib has the potential for the research of cancer diseases, especially advanced non-small cell lung cancer (NSCLC) with EGFR ex20ins ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Firmonertinib mesylate inhibits EGFR active mutations as well as the T790M acquired resistant mutation. Firmonertinib mesylate has the potential for the research of cancer diseases, especially advanced non-small cell lung cancer (NSCLC) with EGFR ex20ins ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
NT219 affects IRS1/2 degradation and inhibits STAT3 phosphorylation. NT219 has the potential for the research of cancer ...
Manufactured by:Shine Technologies based inJanesville, WISCONSIN (USA)
SHINE Technologies’ production process results in molybdenum-99 that is of high quality and high purity, resulting in Mo-99 that has high specific activity and is ready for delivery to our medical customers. We believe our production of Mo-99 in the United States will contribute to the reliability of SHINE’s supply in a time of chronic shortages of medical ...
Manufactured by:ProImmune Ltd. based inOxford, UNITED KINGDOM
A clear solution to a long-standing problem. Detecting and targeting specific MHC-peptide complexes is of material interest for understanding many disease conditions better and for developing novel therapeutic interventions. It has been very challenging to develop antibodies that bind selectively to an MHC-peptide combination over a more general MHC ...
Manufactured by:AnaSpec based inFremont, CALIFORNIA (USA)
Matrix metalloproteinases (MMPs) belong to a family of secreted or membrane-associated zinc endopeptidases capable of digesting extracellular matrix components. MMP-9 (92-kDa gelatinase, collagenase-IV) is involved in a number of diseases such as cancer, angiogenesis, alopecia, and metastasis. MMP-9 is secreted as zymogen with prodomain, gelatin-binding domain ...
Manufactured by:Röchling SE & Co. KG based inMannheim, GERMANY
Care of the patient is shifting towards prevention and early detection of disease. With an increasing presence of cancer, autoimmune and infectious diseases, the need for point-of-care diagnostics is on the rise. Röchling Medical partners with our customers to create medical innovations to help transform how patients are diagnosed and ...
Manufactured by:The Menarini Group based inFlorence, ITALY
Elacestrant is a selective estrogen receptor degrader (SERD) evaluated for potential use as a once daily oral treatment in patients with estrogen receptor positive (ER+)/HER2- advanced or metastatic breast cancer. Studies completed to date, including the positive results from the EMERALD phase 3 trial, indicate that the compound has the potential for use as a single agent or in combination with ...
by:LIXTE Biotechnology Holdings, Inc. based inPasadena, CALIFORNIA (USA)
Designated as our LB-200 series of compounds, these have potential use in the prevention and treatment of neurodegenerative diseases. The series has the potential to be the most effective in its class and may be useful for the treatment of chronic hereditary diseases, such as Gaucher’s disease, in addition to cancer and ...
Manufactured by:Blue Earth Diagnostics based inOxford, UNITED KINGDOM
Diagnostic nuclear medicine is a type of molecular imaging that uses very small amounts of radioisotopes attached to a targeting molecule (radiopharmaceutical1) to diagnose complex diseases such as cancer. Radiopharmaceuticals are able to show the physiological function of the body rather than just the anatomy. Changes in the biochemical activity of cells often ...
by:Pars Isotope Co based inTehran, IRAN
Designed for the extraction of technetium-99m (Tc-99m) in the form of a sodium pertechnetate solution, it serves as an essential tool for labeling SPECT diagnostic radiopharmaceutical kits. It facilitates the diagnosis of various cancers and diseases. Tc-99m is favored in medical diagnostics due to its half-life of 6.01 hours, which limits unnecessary radiation ...
Manufactured by:BioMaxima SA based inLublin, POLAND
BioMaxima was the first in Poland to start production of rapid diagnostic tests. The most popular and flagship product is the fecal occult blood test used for the diagnosis of colorectal cancer. We offer tests for infectious diseases, inflammatory and cancer markers and addictive drugs. Every year, based on the requirements of customers, we are ...
Manufactured by:Everlife CPC Diagnostics Pvt. Ltd. based inChennai, INDIA
ichroma™ II is a compact fully automatic hormone analyzer ,easy-to-use fluorescence-based POCT technology by Boditech POCT. ichroma 2 is used to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases. diseases, autoimmune ...
Manufactured by:AMS Biotechnology (Europe) Ltd. based inAbingdon, UNITED KINGDOM
Breast cancer with adjacent normal breast tissue array (2012 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 12 cases/24 cores, repalcing BR245. Breast carcinoma with adjacent normal breast tissue microarray, containing 10 cases of invasive carcinoma of no special type, 2 adjacent normal breast tissue, duplicate cores per ...
Manufactured by:iThera Medical GmbH based inMunich, GERMANY
Based on our proven CE-marked MSOT Acuity Echo system further non-CE-certified, customized MSOT Acuity Echo research systems are available upon request to match your clinical research needs in optoacoustic imaging. iThera Medical has been providing optoacoustic systems for clinical research since 2014. Two product lines, the MSOT Acuity Echo and the RSOM Explorer C50 research system, enable ...
Manufactured by:Breathomix based inLeiden, NETHERLANDS
Generally speaking, integrated databases contain information collected from more than one data source. Combining data from multiple sources yields increased statistical power to identify important relationships between data elements. Integrated databases are commonly being used by research institutes, pharmaceutical companies, and regulatory agencies. The digital transformation of healthcare ...
Manufactured by:Pepex Biomedical, Inc. based inNorcross, GEORGIA (US) (USA)
3E Catheter Style Sensor Module for In-Hospital Diagnostics for Trend Monitoring for In-Hospital Diagnostics. ...
Manufactured by:AVEO Pharmaceuticals, Inc. based inBoston, MASSACHUSETTS (USA)
The Notch 3 signaling pathway is important in cell-to-cell communication involving gene regulation mechanisms that control multiple cell differentiation processes during the entire life cycle. Scientific literature has implicated the Notch 3 receptor pathway in multiple diseases, including cancer, cardiovascular diseases and neurodegenerative ...
Manufactured by:Oxford Vacmedix UK Limited based inOxford, UNITED KINGDOM
Tumours can often avoid being targeted by these T Cells by looking like a cell found normally in the body often referred to as “self”. If a group of T Cells can be encouraged to recognise these tumours as foreign and not self then they will attack the tumour and provide an effective treatment against it. Injecting a preparation that stimulates these T Cells effectively vaccinates the ...